UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 15, 2020
Westlake Chemical Corporation
(Exact name of registrant as specified in its charter)
| | | | |
Delaware | | 001-32260 | | 76-0346924 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
| | |
2801 Post Oak Boulevard, Suite 600 Houston, Texas | | 77056 |
(Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (713) 960-9111
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Common Stock 1.625% Senior Notes due 2029 | | WLK WLK 29 | | The New York Stock Exchange The New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07. | Submission of Matters to a Vote of Security Holders. |
At the annual meeting of stockholders of Westlake Chemical Corporation (the “Company”) held on May 15, 2020, three matters were voted upon by the Company’s stockholders: (1) four members of the board of directors were elected; (2) the advisory vote to approve named executive officer compensation was approved; and (3) the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020 was ratified. The following tabulation sets forth the number of votes cast for, against or withheld and the number of abstentions and broker non-votes, as applicable.
| | | | | | | | | | | | |
Election of Directors | | Votes For | | | Votes Withheld | | | Broker Non-Votes | |
Marius A. Haas | | | 96,639,797 | | | | 25,700,768 | | | | 2,048,270 | |
Dorothy C. Jenkins | | | 103,438,617 | | | | 18,901,948 | | | | 2,048,270 | |
Kimberly S. Lubel | | | 122,175,974 | | | | 164,591 | | | | 2,048,270 | |
Jeffrey W. Sheets | | | 121,672,870 | | | | 667,695 | | | | 2,048,270 | |
| | | | | | | | | | | | | | | | |
| | Votes For | | | Votes Against | | | Abstentions | | | Broker Non-Votes | |
Advisory vote to approve named executive officer compensation | | | 118,253,895 | | | | 4,048,036 | | | | 38,634 | | | | 2,048,270 | |
| | | | | | | | | | | | |
| | Votes For | | | Votes Against | | | Abstentions | |
Ratification of the appointment of PricewaterhouseCoopers LLP | | | 123,433,598 | | | | 953,037 | | | | 2,200 | |
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
The following exhibit is furnished herewith:
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | |
| | | | | | WESTLAKE CHEMICAL CORPORATION |
| | | | | | |
Date: May 18, 2020 | | | | By: | | /s/Albert Chao |
| | | | | | Albert Chao President and Chief Executive Officer |